Understanding how variations in RNA sequences affect blood cell development
Mechanisms and consequences of 3'UTR isoform diversity in erythropoiesis
['FUNDING_FELLOWSHIP'] · UNIVERSITY OF PENNSYLVANIA · NIH-10925235
This study is looking at how certain parts of our genes, called 3' untranslated regions, can affect the way blood cells develop and function, which could help us understand conditions like anemia and leukemia better.
Quick facts
| Phase | ['FUNDING_FELLOWSHIP'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PENNSYLVANIA (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-10925235 on ClinicalTrials.gov |
What this research studies
This research investigates the role of 3' untranslated regions (3'UTRs) in the development of blood cells, particularly focusing on how variations in these regions can influence gene expression. By examining alternative polyadenylation, a process that alters the length and composition of 3'UTRs, the study aims to uncover how these changes affect the stability and translation of messenger RNAs in blood cells. The research employs advanced sequencing techniques to map these variations and their regulatory mechanisms, which could provide insights into conditions like anemia and leukemia.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with blood disorders such as acute erythroblastic leukemia, acute erythroid leukemia, or anemia.
Not a fit: Patients with non-hematological conditions or those without any blood-related disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating blood disorders by targeting the mechanisms that regulate blood cell development.
How similar studies have performed: Other research has shown promising results in understanding RNA processing in blood cells, indicating that this approach could yield valuable insights.
Where this research is happening
PHILADELPHIA, UNITED STATES
- UNIVERSITY OF PENNSYLVANIA — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GAZZARA, MATTHEW ROBERT — UNIVERSITY OF PENNSYLVANIA
- Study coordinator: GAZZARA, MATTHEW ROBERT
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.